SCHEMBL10200718

SCHEMBL10200718

CC1OC(=O)C[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13502510 1.00 — —
SCHEMBL10110588 1.00 — —
SCHEMBL14420274 1.00 — —
SCHEMBL364043 1.00 — —
SCHEMBL13983807 1.00 — —
SCHEMBL14420270 1.00 — —
SCHEMBL13947336 0.86 SMN1; SMN2 (0.55) —
SCHEMBL12908952 0.86 SMN1; SMN2 (0.55) —
Methacrylic Acid SCHEMBL19376986 0.82 SMN1; SMN2 (0.40) —
SCHEMBL14787119 0.75 SMN1; SMN2 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165319-A1 INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-28 — — US disclosed
Send feedback